The 'polilaminina' refers to a synthesized form of laminin, developed in a laboratory, which consists of multiple laminin molecules linked together. This synthetic approach aims to provide a therapeutic agent that can be administered to patients, potentially aiding in the repair or preservation of neural pathways following injury.
Impact: High. The development of synthesized polilaminina represents a significant advancement, moving from understanding laminin's biological role to creating a tangible therapeutic agent for clinical application.
In the source video, this keypoint occurs from 00:45:36 to 00:46:42.
Sources in support: Felipe Hime (Astrophysicist)

